Global Prion Disease Drug Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prion Disease Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antidepressant
1.2.3 Antipsychotic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prion Disease Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prion Disease Drug Market Perspective (2020-2031)
2.2 Global Prion Disease Drug Growth Trends by Region
2.2.1 Global Prion Disease Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prion Disease Drug Historic Market Size by Region (2020-2025)
2.2.3 Prion Disease Drug Forecasted Market Size by Region (2026-2031)
2.3 Prion Disease Drug Market Dynamics
2.3.1 Prion Disease Drug Industry Trends
2.3.2 Prion Disease Drug Market Drivers
2.3.3 Prion Disease Drug Market Challenges
2.3.4 Prion Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prion Disease Drug Players by Revenue
3.1.1 Global Top Prion Disease Drug Players by Revenue (2020-2025)
3.1.2 Global Prion Disease Drug Revenue Market Share by Players (2020-2025)
3.2 Global Prion Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prion Disease Drug Revenue
3.4 Global Prion Disease Drug Market Concentration Ratio
3.4.1 Global Prion Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prion Disease Drug Revenue in 2024
3.5 Global Key Players of Prion Disease Drug Head office and Area Served
3.6 Global Key Players of Prion Disease Drug, Product and Application
3.7 Global Key Players of Prion Disease Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prion Disease Drug Breakdown Data by Type
4.1 Global Prion Disease Drug Historic Market Size by Type (2020-2025)
4.2 Global Prion Disease Drug Forecasted Market Size by Type (2026-2031)
5 Prion Disease Drug Breakdown Data by Application
5.1 Global Prion Disease Drug Historic Market Size by Application (2020-2025)
5.2 Global Prion Disease Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prion Disease Drug Market Size (2020-2031)
6.2 North America Prion Disease Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prion Disease Drug Market Size by Country (2020-2025)
6.4 North America Prion Disease Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prion Disease Drug Market Size (2020-2031)
7.2 Europe Prion Disease Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prion Disease Drug Market Size by Country (2020-2025)
7.4 Europe Prion Disease Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prion Disease Drug Market Size (2020-2031)
8.2 Asia-Pacific Prion Disease Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prion Disease Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Prion Disease Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prion Disease Drug Market Size (2020-2031)
9.2 Latin America Prion Disease Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prion Disease Drug Market Size by Country (2020-2025)
9.4 Latin America Prion Disease Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prion Disease Drug Market Size (2020-2031)
10.2 Middle East & Africa Prion Disease Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prion Disease Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Prion Disease Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Prion Disease Drug Introduction
11.1.4 Novartis AG Revenue in Prion Disease Drug Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Prion Disease Drug Introduction
11.2.4 Merck KGaA Revenue in Prion Disease Drug Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma Prion Disease Drug Introduction
11.3.4 Aurobindo Pharma Revenue in Prion Disease Drug Business (2020-2025)
11.3.5 Aurobindo Pharma Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Prion Disease Drug Introduction
11.4.4 AstraZeneca Revenue in Prion Disease Drug Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Prion Disease Drug Introduction
11.5.4 Abbott Revenue in Prion Disease Drug Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Ionis Pharmaceuticals
11.6.1 Ionis Pharmaceuticals Company Details
11.6.2 Ionis Pharmaceuticals Business Overview
11.6.3 Ionis Pharmaceuticals Prion Disease Drug Introduction
11.6.4 Ionis Pharmaceuticals Revenue in Prion Disease Drug Business (2020-2025)
11.6.5 Ionis Pharmaceuticals Recent Development
11.7 Lannett
11.7.1 Lannett Company Details
11.7.2 Lannett Business Overview
11.7.3 Lannett Prion Disease Drug Introduction
11.7.4 Lannett Revenue in Prion Disease Drug Business (2020-2025)
11.7.5 Lannett Recent Development
11.8 Astellas Pharma Inc.
11.8.1 Astellas Pharma Inc. Company Details
11.8.2 Astellas Pharma Inc. Business Overview
11.8.3 Astellas Pharma Inc. Prion Disease Drug Introduction
11.8.4 Astellas Pharma Inc. Revenue in Prion Disease Drug Business (2020-2025)
11.8.5 Astellas Pharma Inc. Recent Development
11.9 Sawai Pharmaceutical
11.9.1 Sawai Pharmaceutical Company Details
11.9.2 Sawai Pharmaceutical Business Overview
11.9.3 Sawai Pharmaceutical Prion Disease Drug Introduction
11.9.4 Sawai Pharmaceutical Revenue in Prion Disease Drug Business (2020-2025)
11.9.5 Sawai Pharmaceutical Recent Development
11.10 Elite Pharmaceuticals, Inc.
11.10.1 Elite Pharmaceuticals, Inc. Company Details
11.10.2 Elite Pharmaceuticals, Inc. Business Overview
11.10.3 Elite Pharmaceuticals, Inc. Prion Disease Drug Introduction
11.10.4 Elite Pharmaceuticals, Inc. Revenue in Prion Disease Drug Business (2020-2025)
11.10.5 Elite Pharmaceuticals, Inc. Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Prion Disease Drug Introduction
11.11.4 Teva Pharmaceuticals Revenue in Prion Disease Drug Business (2020-2025)
11.11.5 Teva Pharmaceuticals Recent Development
11.12 Bristol Myers Squibb
11.12.1 Bristol Myers Squibb Company Details
11.12.2 Bristol Myers Squibb Business Overview
11.12.3 Bristol Myers Squibb Prion Disease Drug Introduction
11.12.4 Bristol Myers Squibb Revenue in Prion Disease Drug Business (2020-2025)
11.12.5 Bristol Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Prion Disease Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antidepressant
Table 3. Key Players of Antipsychotic Agents
Table 4. Key Players of Others
Table 5. Global Prion Disease Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prion Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Prion Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Prion Disease Drug Market Share by Region (2020-2025)
Table 9. Global Prion Disease Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Prion Disease Drug Market Share by Region (2026-2031)
Table 11. Prion Disease Drug Market Trends
Table 12. Prion Disease Drug Market Drivers
Table 13. Prion Disease Drug Market Challenges
Table 14. Prion Disease Drug Market Restraints
Table 15. Global Prion Disease Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Prion Disease Drug Market Share by Players (2020-2025)
Table 17. Global Top Prion Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prion Disease Drug as of 2024)
Table 18. Ranking of Global Top Prion Disease Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Prion Disease Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Prion Disease Drug, Headquarters and Area Served
Table 21. Global Key Players of Prion Disease Drug, Product and Application
Table 22. Global Key Players of Prion Disease Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prion Disease Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Prion Disease Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Prion Disease Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Prion Disease Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Prion Disease Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Prion Disease Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Prion Disease Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Prion Disease Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Prion Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Prion Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Prion Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Prion Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Prion Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Prion Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Prion Disease Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Prion Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Prion Disease Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Prion Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Prion Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Prion Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Prion Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Prion Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Prion Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Prion Disease Drug Product
Table 50. Novartis AG Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Merck KGaA Company Details
Table 53. Merck KGaA Business Overview
Table 54. Merck KGaA Prion Disease Drug Product
Table 55. Merck KGaA Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 56. Merck KGaA Recent Development
Table 57. Aurobindo Pharma Company Details
Table 58. Aurobindo Pharma Business Overview
Table 59. Aurobindo Pharma Prion Disease Drug Product
Table 60. Aurobindo Pharma Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 61. Aurobindo Pharma Recent Development
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Prion Disease Drug Product
Table 65. AstraZeneca Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Prion Disease Drug Product
Table 70. Abbott Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Ionis Pharmaceuticals Company Details
Table 73. Ionis Pharmaceuticals Business Overview
Table 74. Ionis Pharmaceuticals Prion Disease Drug Product
Table 75. Ionis Pharmaceuticals Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 76. Ionis Pharmaceuticals Recent Development
Table 77. Lannett Company Details
Table 78. Lannett Business Overview
Table 79. Lannett Prion Disease Drug Product
Table 80. Lannett Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 81. Lannett Recent Development
Table 82. Astellas Pharma Inc. Company Details
Table 83. Astellas Pharma Inc. Business Overview
Table 84. Astellas Pharma Inc. Prion Disease Drug Product
Table 85. Astellas Pharma Inc. Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 86. Astellas Pharma Inc. Recent Development
Table 87. Sawai Pharmaceutical Company Details
Table 88. Sawai Pharmaceutical Business Overview
Table 89. Sawai Pharmaceutical Prion Disease Drug Product
Table 90. Sawai Pharmaceutical Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 91. Sawai Pharmaceutical Recent Development
Table 92. Elite Pharmaceuticals, Inc. Company Details
Table 93. Elite Pharmaceuticals, Inc. Business Overview
Table 94. Elite Pharmaceuticals, Inc. Prion Disease Drug Product
Table 95. Elite Pharmaceuticals, Inc. Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 96. Elite Pharmaceuticals, Inc. Recent Development
Table 97. Teva Pharmaceuticals Company Details
Table 98. Teva Pharmaceuticals Business Overview
Table 99. Teva Pharmaceuticals Prion Disease Drug Product
Table 100. Teva Pharmaceuticals Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 101. Teva Pharmaceuticals Recent Development
Table 102. Bristol Myers Squibb Company Details
Table 103. Bristol Myers Squibb Business Overview
Table 104. Bristol Myers Squibb Prion Disease Drug Product
Table 105. Bristol Myers Squibb Revenue in Prion Disease Drug Business (2020-2025) & (US$ Million)
Table 106. Bristol Myers Squibb Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report


List of Figures
Figure 1. Prion Disease Drug Picture
Figure 2. Global Prion Disease Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prion Disease Drug Market Share by Type: 2024 VS 2031
Figure 4. Antidepressant Features
Figure 5. Antipsychotic Agents Features
Figure 6. Others Features
Figure 7. Global Prion Disease Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Prion Disease Drug Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Prion Disease Drug Report Years Considered
Figure 14. Global Prion Disease Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prion Disease Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prion Disease Drug Market Share by Region: 2024 VS 2031
Figure 17. Global Prion Disease Drug Market Share by Players in 2024
Figure 18. Global Top Prion Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prion Disease Drug as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prion Disease Drug Revenue in 2024
Figure 20. North America Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prion Disease Drug Market Share by Country (2020-2031)
Figure 22. United States Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prion Disease Drug Market Share by Country (2020-2031)
Figure 26. Germany Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prion Disease Drug Market Share by Region (2020-2031)
Figure 34. China Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prion Disease Drug Market Share by Country (2020-2031)
Figure 42. Mexico Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prion Disease Drug Market Share by Country (2020-2031)
Figure 46. Turkey Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prion Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Novartis AG Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 50. Merck KGaA Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 51. Aurobindo Pharma Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 52. AstraZeneca Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 53. Abbott Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 54. Ionis Pharmaceuticals Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 55. Lannett Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 56. Astellas Pharma Inc. Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 57. Sawai Pharmaceutical Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 58. Elite Pharmaceuticals, Inc. Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 59. Teva Pharmaceuticals Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in Prion Disease Drug Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit